Company Profile
Akero Therapeutics Stock Price, News & Analysis
- Ticker:
- AKRO
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Why the stock is moving
Current closing-price context is not available for AKRO.
Company overview
Business overview
Akero Therapeutics is a metabolic-liver biotech focused on MASH and related liver-disease biology.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Akero sits in specialty biopharmaceuticals.
Business Model Characteristics
Its model depends on liver-disease data, dose optimization, and the potential to build a differentiated metabolic franchise.
Position Within the Biotechnology Landscape
Akero is one of the more closely watched MASH names because efficacy signals can move the stock sharply.
Future catalysts
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does Akero Therapeutics do?
Akero Therapeutics is a metabolic-liver biotech focused on MASH and related liver-disease biology.
On which exchange is AKRO stock listed?
Akero Therapeutics (AKRO) is associated with NASDAQ, United States, Biopharma.
What is Akero?
Akero Therapeutics is a metabolic-liver biotech focused on MASH and related liver-disease biology.
Which conditions is Akero Therapeutics targeting with Akero?
Akero Therapeutics is associated with metabolic disease based on its company overview and current catalyst commentary.
What is Therapeutics?
Akero Therapeutics is a metabolic-liver biotech focused on MASH and related liver-disease biology.